Molecular studies on thyrotropin (TSH) receptor and anti-TSH receptor antibodies.

Cloning of TSHR gene and some subsequent studies using the gene were described. Enormous numbers of studies have been performed since the cloning of TSHR gene. Recent molecular studies on TSH receptor and TSHRAb gave various impacts on thyroidology and are resolving past problems. We mainly focused on regulation, processing and glycosylation, TSH- and TSHRAb binding sites, T cell epitopes, and signal transduction of TSHR. Furthermore, we isolated and characterized TSHRAb genes using lymphocytes producing monoclonal TSHRAb obtained from patients with Graves' disease and primary hypothyroidism. Thus, both antigen and antibody genes are cloned. Combined use of these genes will help to investigate the interactions between TSHR and TSHRAb, and may be expected to contribute to the understanding of molecular mechanisms underlying the pathogenesis of autoimmune thyroid disease as well as the physiology of the thyroid gland.

[1]  T. Akamizu,et al.  Establishment and characterization of an antihuman thyrotropin (TSH) receptor-specific CD4+ T cell line from a patient with Graves' disease: evidence for multiple T cell epitopes on the TSH receptor including the transmembrane domain. , 1995, Thyroid : official journal of the American Thyroid Association.

[2]  T. Yanagawa,et al.  Production of thyroid-stimulating antibodies in mice by immunization with T-cell epitopes of human thyrotropin receptor. , 1995, Endocrinology.

[3]  F. Matsuda,et al.  Isolation of Epstein-Barr-virus-transformed lymphocytes producing IgG class monoclonal antibodies using a magnetic cell separator (MACS): preparation of thyroid-stimulating IgG antibodies from patients with Graves' disease. , 1995, Biochemical and biophysical research communications.

[4]  F. Matsuda,et al.  Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema. , 1994, The Journal of clinical endocrinology and metabolism.

[5]  N. Carter,et al.  A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q , 1994, Nature Genetics.

[6]  T. Akamizu,et al.  Possible difference in glycosylation of the thyrotropin receptor among species. , 1994, Biochemical and biophysical research communications.

[7]  T. Akamizu,et al.  The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation. , 1994, Molecular endocrinology.

[8]  F. Matsuda,et al.  Variable regions of Ig heavy chain genes encoding antithyrotropin receptor antibodies of patients with Graves' disease. , 1994, Journal of immunology.

[9]  T. Akamizu,et al.  Recent progress in TSH receptor studies with a new concept of "autoimmune TSH receptor disease". , 1994, Endocrine journal.

[10]  M. Prummel,et al.  Molecular cloning and characterization of genes for antibodies generated by orbital tissue-infiltrating B-cells in Graves' ophthalmopathy. , 1994, The Journal of clinical endocrinology and metabolism.

[11]  T. Akamizu,et al.  Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies. , 1993, The Journal of clinical endocrinology and metabolism.

[12]  D. Russo,et al.  Human organ-specific autoimmune disease. Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic immunodominant region and restricted immunoglobulin gene usage in the target organ. , 1993, The Journal of clinical investigation.

[13]  H. Imura,et al.  Chimeric studies of the extracellular domain of the rat thyrotropin (TSH) receptor: amino acids (268-304) in the TSH receptor are involved in ligand high affinity binding, but not in TSH receptor-specific signal transduction. , 1993, Endocrine journal.

[14]  M. Atassi,et al.  Autoimmune T-cell recognition sites of human thyrotropin receptor in Graves' disease , 1993, Molecular and Cellular Endocrinology.

[15]  T. Akamizu,et al.  Role of cysteine residues in the extracellular domain and exoplasmic loops of the transmembrane domain of the TSH receptor: effect of mutation to serine on TSH receptor activity and response to thyroid stimulating autoantibodies. , 1992, Biochemical and biophysical research communications.

[16]  A. Shenker,et al.  Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. , 1992, The Journal of biological chemistry.

[17]  T. Akamizu,et al.  Opposite regulation of deoxyribonucleic acid synthesis and iodide uptake in rat thyroid cells by basic fibroblast growth factor: correlation with opposite regulation of c-fos and thyrotropin receptor gene expression. , 1992, Endocrinology.

[18]  A. Weetman,et al.  T cell responses to synthetic TSH receptor peptides in Graves' disease , 1992, Clinical and experimental immunology.

[19]  J. Dumont,et al.  Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. , 1992, Physiological reviews.

[20]  T. Akamizu,et al.  Characterization of the 5'-flanking region of the rat thyrotropin receptor gene. , 1992, Molecular endocrinology.

[21]  V. Garsky,et al.  Peptide sequences from the hypervariable regions of two monoclonal anti-idiotypic antibodies against the thyrotropin (TSH) receptor are similar to TSH and inhibit TSH-increased cAMP production in FRTL-5 thyroid cells. , 1992, The Journal of biological chemistry.

[22]  T. Akamizu,et al.  Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. , 1992, Molecular endocrinology.

[23]  T. Akamizu,et al.  Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients. , 1991, Biochemical and biophysical research communications.

[24]  T. Akamizu,et al.  Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors. Relationship of functional and immunogenic domains. , 1991, The Journal of biological chemistry.

[25]  B. Rapoport,et al.  A human Fab fragment specific for thyroid peroxidase generated by cloning thyroid lymphocyte-derived immunoglobulin genes in a bacteriophage lambda library. , 1991, Biochemical and biophysical research communications.

[26]  T. Akamizu,et al.  Increases in cytosolic Ca++ down regulate thyrotropin receptor gene expression by a mechanism different from the cAMP signal. , 1991, Biochemical and biophysical research communications.

[27]  P. Gearhart,et al.  Autoantibodies to thyroglobulin are encoded by diverse V-gene segments and recognize restricted epitopes. , 1990, Journal of immunology.

[28]  C. Kozak,et al.  Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Akamizu,et al.  A microsequencing approach to identify proteins which appear to interact with thyrotropin in rat FRTL-5 thyroid cells. , 1990, Biochemical and biophysical research communications.

[30]  T. Akamizu,et al.  Thyrotropin receptor processing and interaction with thyrotropin. , 1990, Biochemical and biophysical research communications.

[31]  M. Lerman,et al.  Cloning and characterization of a cDNA that encodes a 70-kDa novel human thyroid autoantigen. , 1989, The Journal of biological chemistry.

[32]  Y. Ichikawa,et al.  Monoclonal antibodies to the thyrotropin receptor bind to a 56-kDa subunit of the thyrotropin receptor and show heterogeneous bioactivities. , 1988, The Journal of biological chemistry.

[33]  K. Burman,et al.  Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen. , 1988, Journal of immunology.

[34]  P. Laccetti,et al.  Multicomponent structure of the thyrotropin receptor: relationship to Graves' disease. , 1983, Life sciences.

[35]  P. Vitti,et al.  Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Akamizu,et al.  Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition. , 1995, European journal of endocrinology.

[37]  T. Akamizu,et al.  Further studies of amino acids (268-304) in thyrotropin (TSH)--lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure. , 1994, Thyroid : official journal of the American Thyroid Association.

[38]  T. Yanagawa,et al.  Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor. , 1994, Thyroid : official journal of the American Thyroid Association.

[39]  J. Riley,et al.  Structure and physical map of 64 variable segments in the 3′ 0.8–megabase region of the human immunoglobulin heavy–chain locus , 1993, Nature Genetics.

[40]  L. Kohn,et al.  Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. , 1993, Molecular endocrinology.

[41]  E. Avvedimento,et al.  Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells. , 1992, Endocrinology.

[42]  D. Burton,et al.  Variable region sequence of a human monoclonal thyroid peroxidase autoantibody. , 1992, Autoimmunity.

[43]  B. Prabhakar,et al.  The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies. , 1991, Thyroid : official journal of the American Thyroid Association.

[44]  T. Akamizu,et al.  Receptors of the thyroid: the thyrotropin receptor is only the first violinist of a symphony orchestra. , 1989, Advances in experimental medicine and biology.